NGEN
NervGen Pharma Corp

944
Mkt Cap
$368.52M
Volume
210,899.00
52W High
$6.30
52W Low
$1.50
PE Ratio
-17.87
NGEN Fundamentals
Price
$4.63
Prev Close
$4.77
Open
$4.76
50D MA
$4.51
Beta
0.76
Avg. Volume
137,062.64
EPS (Annual)
-$0.2603
P/B
-160.76
Loading...
Loading...
NervGen Pharma Corp. operates as a clinical stage biotech company. It provides development of treatment that enables the nervous system to repair itself following damage, whether due to injury or disease. The company was founded by Harold Punnett and William Joseph Radvak on January 19, 2017 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of NervGen Pharma Corp?
What is the 52-week high for NervGen Pharma Corp?
What is the 52-week low for NervGen Pharma Corp?
What is NervGen Pharma Corp stock price today?
What was NervGen Pharma Corp stock price yesterday?
What is the PE ratio of NervGen Pharma Corp?
What is the Price-to-Book ratio of NervGen Pharma Corp?
What is the 50-day moving average of NervGen Pharma Corp?

Latest NGEN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.